Sub-Urban Brands, Inc.

Sub-Urban Brands, Inc.

SUUB
Sub-Urban Brands, Inc.US flagOther OTC
0.00
USD
+0.00
- -
81,212.00Market Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Consumer Cyclical
Industry
Apparel - Manufacturers
Address
8723 Bellanca Avenue Los Angeles CA United States of America 90045
IPO Date
Jul 24, 2009
Business
Sub-Urban Brands, Inc. (SUUB) operates as a lifestyle apparel brand company focused on designing, selling, and marketing apparel products including shirts, outerwear, sweatshirts, T-shirts, and accessories for the urban, street, and board apparel markets. The company offers core brands such as Mash Culture Lab and WHITEBOY, with WHITEBOY targeting men and girls; inventory production is fully outsourced while the company pursues intellectual property development and third-party brand acquisitions. Headquartered in Santa Monica, California, at 1137 6th Street Suite 301, Sub-Urban Brands primarily serves the U.S. retail apparel and accessories market through these product lines. Formerly known as DP&D, Inc., the company acquired its wholly-owned subsidiary Sub-Urban Industries, Inc. on May 11, 2006, to expand its operational scope. No major recent partnerships, funding rounds, acquisitions, new product launches, or strategic shifts have been reported in the last 1-2 years, with the company maintaining a low public profile as an inactive OTC-traded entity.